Fanapt



Indications and Reactions:

Role Indications Reactions
Primary
Schizophrenia 39.6%
Bipolar Disorder 12.6%
Psychotic Disorder 9.3%
Schizoaffective Disorder 9.3%
Depression 3.6%
Anxiety 3.0%
Pain 2.7%
Extrapyramidal Disorder 2.5%
Hypertension 2.5%
Affective Disorder 1.9%
Hypothyroidism 1.9%
Paranoia 1.6%
Bipolar I Disorder 1.4%
Dyspepsia 1.4%
Insomnia 1.4%
Musculoskeletal Pain 1.4%
Dry Skin 1.1%
Schizoaffective Disorder Bipolar Type 1.1%
Constipation 0.8%
Diabetes Mellitus 0.8%
Weight Increased 10.1%
Oedema Peripheral 8.1%
Dizziness 7.5%
Orthostatic Hypotension 7.2%
Death 5.9%
Tachycardia 5.9%
Retrograde Ejaculation 5.5%
Nausea 4.9%
Vomiting 4.9%
Hypotension 4.2%
Priapism 4.2%
Drug Ineffective 3.9%
Dyspnoea 3.6%
Palpitations 3.6%
Psychotic Disorder 3.6%
Pulmonary Embolism 3.6%
Sedation 3.6%
Headache 3.3%
Insomnia 3.3%
Somnolence 3.3%
Secondary
Schizophrenia 40.7%
Type 1 Diabetes Mellitus 10.8%
Product Used For Unknown Indication 8.7%
Depression 8.2%
Hypertension 7.8%
Blood Cholesterol Abnormal 3.9%
Affective Disorder 3.5%
Bipolar Disorder 3.0%
Anxiety 2.6%
Psychotic Disorder 1.7%
Bladder Disorder 1.3%
Abnormal Behaviour 0.9%
Constipation 0.9%
Dyslipidaemia 0.9%
Extrapyramidal Disorder 0.9%
Hypothyroidism 0.9%
Osteopenia 0.9%
Osteoporosis 0.9%
Pain 0.9%
Psychiatric Symptom 0.9%
Arthralgia 17.1%
Syncope 9.8%
Weight Increased 8.5%
Snoring 7.3%
Vomiting 7.3%
Pulmonary Embolism 6.1%
Death 4.9%
Schizophrenia 4.9%
Concomitant Disease Progression 3.7%
Pneumonia 3.7%
Respiratory Failure 3.7%
Tachycardia 3.7%
Bladder Disorder 2.4%
Drug Ineffective 2.4%
Dyspnoea 2.4%
Hypoaesthesia 2.4%
Insomnia 2.4%
Mastication Disorder 2.4%
Swollen Tongue 2.4%
Wrong Technique In Drug Usage Process 2.4%
Concomitant
Schizophrenia 20.5%
Product Used For Unknown Indication 19.2%
Bipolar Disorder 12.8%
Depression 9.0%
Attention Deficit/hyperactivity Disorder 5.1%
Psychotic Disorder 5.1%
Hallucination 3.8%
Autism 2.6%
Blood Pressure Increased 2.6%
Body Height Below Normal 2.6%
Gastrooesophageal Reflux Disease 2.6%
Head Circumference Abnormal 2.6%
Sleep Disorder 2.6%
Abnormal Behaviour 1.3%
Anxiety 1.3%
Bipolar I Disorder 1.3%
Contraception 1.3%
Dyslipidaemia 1.3%
Insomnia 1.3%
Rheumatoid Arthritis 1.3%
Wrong Technique In Drug Usage Process 12.0%
No Adverse Event 8.0%
Therapeutic Response Decreased 8.0%
Visual Impairment 8.0%
Angioedema 4.0%
Antipsychotic Drug Level Increased 4.0%
Anxiety 4.0%
Bipolar Disorder 4.0%
Blood Pressure Increased 4.0%
Blood Prolactin Increased 4.0%
Chest Discomfort 4.0%
Completed Suicide 4.0%
Death 4.0%
Gynaecomastia 4.0%
Hallucination 4.0%
Hyperhidrosis 4.0%
Incorrect Dose Administered 4.0%
Increased Appetite 4.0%
Off Label Use 4.0%
Poor Quality Drug Administered 4.0%